Literature DB >> 12960934

The use of proton MRS in the differential diagnosis of brain tumors and tumor-like processes.

Witold Gajewicz1, Wielislaw Papierz, Wiesław Szymczak, Bozena Goraj.   

Abstract

BACKGROUND: Progress in the treatment of brain neoplasms requires accurate identification of tumor type and grade, before a proper treatment plan can be implemented. The aim of our study was to investigate the use of proton magnetic resonance spectroscopy in the differential diagnosis of neoplastic brain tumors and tumor-like processes. MATERIAL/
METHODS: 29 patients with ambiguous CT images of brain mass lesions were examined by MRI. 1H MRS was applied in this group as the primary option to improve differential diagnosis. In each case a routine MRI was taken in three orthogonal planes before and after i.v. administration of Gd-DTPA. 1H MRS was performed at 1.5 T using the PRESS (TE 136 ms) and STEAM (TE 20 ms) single voxel spectroscopy techniques. MRS was performed after i.v. administration of Gd-DTPA. The lesion types according to spectral patterns were compared to postoperative pathology or biopsy results.
RESULTS: MRS-based diagnosis was consistent with pathology results in all cases of astrocytoma, glioblastoma and meningioma. In two cases distinguishing brain metastases from glioblastomas was difficult because of contamination of the voxel with brain tissue. Three cases of anaplastic oligodendrogliomas were misclassified as glioblastomas. In two cases MR spectra indicating an inflammatory-demyelinating process correlated with biopsy results and clinical course.
CONCLUSIONS: 1HMRS proved to be a useful tool in establishing tumor type and differentiating between neoplastic and large inflammatory tumor-like lesions.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12960934

Source DB:  PubMed          Journal:  Med Sci Monit        ISSN: 1234-1010


  5 in total

Review 1.  Efficacy of proton magnetic resonance spectroscopy in neurological diagnosis and neurotherapeutic decision making.

Authors:  Alexander Lin; Brian D Ross; Kent Harris; Willis Wong
Journal:  NeuroRx       Date:  2005-04

Review 2.  A systematic literature review of magnetic resonance spectroscopy for the characterization of brain tumors.

Authors:  W Hollingworth; L S Medina; R E Lenkinski; D K Shibata; B Bernal; D Zurakowski; B Comstock; J G Jarvik
Journal:  AJNR Am J Neuroradiol       Date:  2006-08       Impact factor: 3.825

Review 3.  Spectrum of intracranial incidental findings on pediatric brain magnetic resonance imaging: What clinician should know?

Authors:  Surya N Gupta; Vikash S Gupta; Andrew C White
Journal:  World J Clin Pediatr       Date:  2016-08-08

4.  Monitoring the effects of BCNU chemotherapy Wafers (Gliadel) in glioblastoma multiforme with proton magnetic resonance spectroscopic imaging at 3.0 Tesla.

Authors:  Jonathan P Dyke; Pina C Sanelli; Henning U Voss; Jennifer V Serventi; Philip E Stieg; Theodore H Schwartz; Douglas Ballon; Dikoma C Shungu; Susan C Pannullo
Journal:  J Neurooncol       Date:  2006-09-22       Impact factor: 4.130

5.  The use of short-echo-time 1H MRS for childhood cerebellar tumours prior to histopathological diagnosis.

Authors:  Lisa M Harris; Nigel Davies; Lesley Macpherson; Katharine Foster; Shaheen Lateef; Kal Natarajan; Spyridon Sgouros; Marie-Anne Brundler; Theodoros N Arvanitis; Richard G Grundy; Andrew C Peet
Journal:  Pediatr Radiol       Date:  2007-09-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.